Cystic Fibrosis News

Computer Simulations Point To Key Molecular Basis Of Cystic Fibrosis

Mon, 23 Jun 2008 15:00:13 GMT

Researchers from the University of North Carolina at Chapel Hill have identified a key molecular mechanism that may account for the development of cystic fibrosis, which about 1 in 3000 children are born with in the US every year.

Full text

Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status For The Treatment Of Cystic Fibrosis

Mon, 23 Jun 2008 15:00:13 GMT

Mpex Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration's (FDA) Office of Orphan Products Development has granted Mpex orphan drug designation for levofloxacin solution for inhalation for the treatment of pulmonary infections due to Pseudomonas aeruginosa and other bacteria in patients with cystic fibrosis.

Full text

First Step To Create Cystic Fibrosis Model Using Pigs

Mon, 23 Jun 2008 15:00:12 GMT

Cystic fibrosis is the most common genetic disease in Caucasians. The median lifespan for those with the disease is 36 years, and lung disease is the major cause of mortality.

Full text

Research Promising For Cystic Fibrosis

Mon, 23 Jun 2008 15:00:11 GMT

New U of T research holds promise for developing innovative therapies against cystic fibrosis and may also serve as a model for future therapies against the HIV virus.

Full text

Cystic Fibrosis Development Better Understood

Mon, 23 Jun 2008 15:00:11 GMT

According to a report in the open-access journal PLoSComputational Biology, there is a specific molecularmechanism that could be responsible for the development of cysticfibrosis.

Full text

5 Million Initiative To Enhance Care For Adults With Cystic Fibrosis

Mon, 23 Jun 2008 15:00:10 GMT

The Cystic Fibrosis Foundation has announced the launch of a new $5 million initiative to enhance care for the growing adult CF population.

Full text

Great Strides 2008 - Taking Steps To Cure Cystic Fibrosis, UK

Mon, 23 Jun 2008 15:00:09 GMT

Thousands of people will be taking steps to cure Cystic Fibrosis (CF) this year by taking part in a series of sponsored walks across the UK.

Full text

Cystic Fibrosis Foundation Announces Positive Early Results For Phase 2 Clinical Trial Of VX-770 - An Oral Compound To Treat CF

Mon, 23 Jun 2008 15:00:08 GMT

The Cystic Fibrosis Foundation has announced that VX-770, an oral drug in development that targets a basic defect in CF, showed promising results in an ongoing Phase 2a clinical trial for patients who carry the G551D mutation of CF.

Full text

Positive Early Results For Phase 2 Clinical Trial Of VX-770 For Cystic Fibrosis

Mon, 23 Jun 2008 15:00:08 GMT

Full text

Cystic Fibrosis In Mice

Mon, 23 Jun 2008 15:00:07 GMT

"Drug 'could aid cystic fibrosis'" is the headline on BBC News. The article says that "widely-used antidepressants could prevent infections which shorten the lives of many cystic fibrosis patients".

Full text